Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan

ConclusionsWhile it remains unclear whether financial entanglements improperly influence the contents of UCPG, most Japanese authors received substantial payments from pharmaceutical companies with little or no disclosure. Because insufficient transparency in disclosure of these financial entanglements may compromise the integrity of UCPG, more rigorous regulation and greater disclosure of financial conflicts of interest are needed.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research